White Paper

PBPK modeling that saves you time and money

Format: PDF file | Document type: White Paper | Promoted Content

This content is provided by Lonza Small Molecules, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

PBPK modeling that saves you time and money

Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug development projects meet tight timelines and budget objectives.

In our latest whitepaper, discover how the power of high-quality PBPK modeling will better prepare you for those crucial preclinical and clinical phases.

With estimated savings of up to $2 million, you'll improve productivity and be first to market with life-changing treatments.

Latest content from Lonza Small Molecules

show more

Lonza de-risks drug development through PBPK

Paid for and in partnership with Lonza Small Molecules

The opportunity to de-risk drug development through PBPK

No company wants to progress a molecule through to the clinic only to suffer a bad readout. PBPK modeling services allow companies to predict what absorption challenges may arise in trials, and plan ways to mitigate them.

Related resources from Lonza Small Molecules

Supplier info centre